139 related articles for article (PubMed ID: 34695715)
1. Development and validation of a predictive score for venous thromboembolism in newly diagnosed non-small cell lung cancer.
Li J; Yi J; Hua L; Su Y; Huo M; Dou F; Zhai Z; Zhu M; Zhang S; Zhang Y
Thromb Res; 2021 Dec; 208():45-51. PubMed ID: 34695715
[TBL] [Abstract][Full Text] [Related]
2. Predictors of active cancer thromboembolic outcomes: validation of the Khorana score among patients with lung cancer.
Mansfield AS; Tafur AJ; Wang CE; Kourelis TV; Wysokinska EM; Yang P
J Thromb Haemost; 2016 Sep; 14(9):1773-8. PubMed ID: 27273134
[TBL] [Abstract][Full Text] [Related]
3. [Risk prediction of venous thromboembolism in non-small cell lung cancer patients based on COMPASS-CAT risk assessment model].
Wang YF; Ma F; Liu BL; Yang K; Li JL; Yu L
Zhonghua Zhong Liu Za Zhi; 2020 Apr; 42(4):340-345. PubMed ID: 32375452
[No Abstract] [Full Text] [Related]
4. High plasma levels of soluble P-Selectin and Factor VIII predict venous thromboembolism in non-small cell lung cancer patients: The Thrombo-Nsclc risk score.
Castellón Rubio VE; Segura PP; Muñoz A; Farré AL; Ruiz LC; Lorente JA
Thromb Res; 2020 Dec; 196():349-354. PubMed ID: 32977135
[TBL] [Abstract][Full Text] [Related]
5. A modified Khorana score as a risk assessment tool for predicting venous thromboembolism in newly diagnosed advanced lung cancer.
Li S; Gao P; Qiu J; He X; Mao Y
J Thromb Thrombolysis; 2021 Oct; 52(3):898-903. PubMed ID: 33599857
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of a nomogram to assess postoperative venous thromboembolism risk in patients with stage IA non-small cell lung cancer.
Cai Y; Dong H; Li X; Liu Y; Hu B; Li H; Miao J; Chen Q
Cancer Med; 2023 Jan; 12(2):1217-1227. PubMed ID: 35758614
[TBL] [Abstract][Full Text] [Related]
7. Postoperative venous thromboembolism after surgery for stage IA non-small-cell lung cancer: A single-center, prospective cohort study.
Dong H; Liang X; Gao Y; Cai Y; Li X; Miao J; Wang W; Hu B; Li H
Thorac Cancer; 2022 May; 13(9):1258-1266. PubMed ID: 35315227
[TBL] [Abstract][Full Text] [Related]
8. ALK-Rearranged Non-Small-Cell Lung Cancer Is Associated With a High Rate of Venous Thromboembolism.
Zer A; Moskovitz M; Hwang DM; Hershko-Klement A; Fridel L; Korpanty GJ; Dudnik E; Peled N; Shochat T; Leighl NB; Liu G; Feld R; Burkes R; Wollner M; Tsao MS; Shepherd FA
Clin Lung Cancer; 2017 Mar; 18(2):156-161. PubMed ID: 27913214
[TBL] [Abstract][Full Text] [Related]
9. Identification of risk factors for venous thromboembolism and evaluation of Khorana venous thromboembolism risk assessment in Japanese lung cancer patients.
Hiraide M; Shiga T; Minowa Y; Nakano Y; Yoshioka H; Suzuki K; Yasuda C; Takahashi H; Hama T
J Cardiol; 2020 Jan; 75(1):110-114. PubMed ID: 31416782
[TBL] [Abstract][Full Text] [Related]
10. Venous thromboembolism risk factors in Chinese non-small cell lung cancer patients.
Wang Z; Yan HH; Yang JJ; Wang BC; Chen HJ; Zhou Q; Xu CR; Jiang BY; Wu YL
Support Care Cancer; 2015 Mar; 23(3):635-41. PubMed ID: 25155313
[TBL] [Abstract][Full Text] [Related]
11. Predictors of Venous Thromboembolism and Early Mortality in Lung Cancer: Results from a Global Prospective Study (CANTARISK).
Kuderer NM; Poniewierski MS; Culakova E; Lyman GH; Khorana AA; Pabinger I; Agnelli G; Liebman HA; Vicaut E; Meyer G; Shepherd FA
Oncologist; 2018 Feb; 23(2):247-255. PubMed ID: 28951500
[TBL] [Abstract][Full Text] [Related]
12. The incidence of venous thromboembolism among patients with primary lung cancer.
Chew HK; Davies AM; Wun T; Harvey D; Zhou H; White RH
J Thromb Haemost; 2008 Apr; 6(4):601-8. PubMed ID: 18208538
[TBL] [Abstract][Full Text] [Related]
13. Development and Validation of a Modified Khorana Score for Predicting Venous Thromboembolism in Newly Diagnosed Stage IV Lung Cancer.
Qin Y; Liang X; Wu H; Sun X; Yan S; Wang N; Yuan M; Wang Q; Wu D
Angiology; 2023 Nov; ():33197231213197. PubMed ID: 37924222
[TBL] [Abstract][Full Text] [Related]
14. Venous thromboembolism incidence and risk assessment in lung cancer patients treated with immune checkpoint inhibitors.
Icht O; Darzi N; Shimony S; Jacobi O; Reinhorn D; Landman Y; Mutai R; Averbuch I; Shochat T; Spectre G; Raanani P; Rotem O; Dudnik E; Peled N; Zer A; Leader A
J Thromb Haemost; 2021 May; 19(5):1250-1258. PubMed ID: 33605020
[TBL] [Abstract][Full Text] [Related]
15. Venous thromboembolism incidence and risk factors in non-small cell lung cancer patients receiving first-line systemic therapy.
Hill H; Robinson M; Lu L; Slaughter D; Amin A; Mileham K; Patel JN
Thromb Res; 2021 Dec; 208():71-78. PubMed ID: 34742139
[TBL] [Abstract][Full Text] [Related]
16. Dynamics of D-dimer in non-small cell lung cancer patients receiving radical surgery and its association with postoperative venous thromboembolism.
Ke L; Cui S; Chen S; Hu B; Li H
Thorac Cancer; 2020 Sep; 11(9):2483-2492. PubMed ID: 32657038
[TBL] [Abstract][Full Text] [Related]
17. Derivation, validation and assessment of a novel nomogram-based risk assessment model for venous thromboembolism in hospitalized patients with lung cancer: A retrospective case control study.
Li H; Tian Y; Niu H; He L; Cao G; Zhang C; Kaiweisierkezi K; Luo Q
Front Oncol; 2022; 12():988287. PubMed ID: 36300098
[TBL] [Abstract][Full Text] [Related]
18. Identification of risk factors for venous thromboembolism and validation of the Khorana score in patients with advanced lung cancer: based on the multicenter, prospective Rising-VTE/NEJ037 study data.
Tsubata Y; Kawakado K; Hamai K; Furuya N; Yokoyama T; Saito R; Nakamura A; Masuda T; Hamaguchi M; Kuyama S; Honda R; Senoo T; Nakanishi M; Hotta T; Yamasaki M; Ishikawa N; Fujitaka K; Kubota T; Kobayashi K; Isobe T
Int J Clin Oncol; 2023 Jan; 28(1):69-78. PubMed ID: 36357710
[TBL] [Abstract][Full Text] [Related]
19. Venous thromboembolism with EGFR monoclonal antibody necitumumab in stage IV non-small cell lung cancer: A retrospective cohort analysis.
Young K; Paz-Ares L; Thatcher N; Spigel DR; Shahidi J; Soldatenkova V; Grau G; Kurek R; Shepherd FA
Thromb Res; 2018 Jul; 167():50-56. PubMed ID: 29787943
[TBL] [Abstract][Full Text] [Related]
20. Association between oncogenic status and risk of venous thromboembolism in patients with non-small cell lung cancer.
Dou F; Li H; Zhu M; Liang L; Zhang Y; Yi J; Zhang Y
Respir Res; 2018 May; 19(1):88. PubMed ID: 29743116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
